Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?

The treatment of borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) has evolved with a wider application of neoadjuvant chemotherapy (NACHT). The aim of this study was...

Source: BMC Surgery - September 30, 2023 Category: Surgery Authors: Lu ís Filipe Abreu de Carvalho, Filip Gryspeerdt, Niki Rashidian, Kobe Van Hove, Lambertine Maertens, Suzane Ribeiro, Anne Hoorens and Frederik Berrevoet Tags: Research Source Type: research